Alexion Reports Fourth Quarter and Full Year 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil up around 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Alexion Pharma (ALXN) Tops Q4 EPS by 40c, Revenues Beat
February 4, 2021 8:05 AM ESTAlexion Pharma (NASDAQ: ALXN) reported Q4 EPS of $2.96, $0.40 better than the analyst estimate of $2.56. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.52 billion.
4Q20 total revenues of $1,591.8 million, a 15% increase over 4Q194Q20 GAAP diluted EPS of $2.42; non-GAAP diluted EPS of... More